Abstract
Background
The pathophysiology of cardiovascular disease (CVD) in chronic kidney disease (CKD) remains uncertain, but autonomic dysfunction seems to be involved. The aim of the study is to investigate the cardiac dysautonomia in uremic pediatric individuals through iodine 123 metaiodobenzylguanidine (MIBG) scintigraphy and heart rate variability (HRV) analysis.
Methods and Results
We divided 40 CKD patients (aged 5–21 years) into 4 groups according to the treatment for CKD: conservative (n=7), continuous ambulatory peritoneal dialysis (n=5), hemodialysis (n=13), and kidney transplantation (n=15). Planar and tomographic I-123 MIBG images were acquired, and early and late cardiac uptake, cardiac and lung washout, and regional I-123 MIBG uptake were evaluated. Hemodialysis patients showed increased cardiac washout (P=.002), a heterogeneous pattern of I-123 MIBG distribution (P=.036), and lower values of the low-frequency (LF) component of HRV (P=.040). Subjects undergoing continuous ambulatory peritoneal dialysis had reduced lung washout (P=.030). The cardiac washout correlated positively with parathyroid hormone levels and negatively with creatinine clearance. There was a significant negative association between the LF component and cardiac washout.
Conclusions
Uremic cardiac dysautonomia may be characterized by a decreased LF component of HRV, increased I-123 MIBG washout, and a heterogeneous distribution pattern in the left ventricular walls; these abnormalities were not present after kidney transplantation.
Similar content being viewed by others
References
Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(Suppl 1): S117–31.
Kohlhagen J, Kelly J. Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure. Nephrology (Carlton) 2003;8:274–9.
Frankel A, Brown E, Wingfield D. Management of chronic kidney disease. BMJ 2005;330:1039–40.
Kurata C, Wakabayashi Y, Shouda S, Okayama K, Yamamoto T, Ishikawa A, et al. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Med 1995;36:2037–43.
Kurata C, Uehara A, Sugi T, Ishikawa A, Fujita K, Yonemura K, et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 2000;84:312–9.
Miyanaga H, Yoneyama S, Kamitani T, Kawasaki S, Takahashi T, Kunishige H. Abnormal myocardial uptake and clearance of 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol 1996;3(Pt 1): 508–15.
Kersh ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K. Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 1974;290:650–3.
Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 1975;15: 424–9.
Campese VM, Kogosov E, Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 1995;26:861–5.
London GM, Fabiani F, Marchais SJ, De Vernejoul MC, Guerin AP, Safar ME, et al. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 1987;31:973–80.
Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912–8.
Cloarec-Blanchard L, Girard A, Houhou S, Grunfeld JP, Elghozi JL. Spectral analysis of short-term blood pressure and heart rate variability in uremic patients. Kidney Int Suppl 1992;37:S14–8.
Axelrod S, Lishner M, Oz O, Bernheim J, Ravid M. Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron 1987;45:202–6.
Tory K, Sallay P, Toth-Heyn P, Szabo A, Szabo A, Tulassay T, et al. Signs of autonomic neuropathy in childhood uremia. Pediatr Nephrol 2001;16:25–8.
Miltenyi G, Tory K, Stubnya G, Toth-Heyn P, Vasarhelyi B, Sallay P, et al. Monitoring cardiovascular changes during hemodialysis in children. Pediatr Nephrol 2001;16:19–24.
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67.
Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A Jr, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol 1999;34:912–48.
DePuey EG, Port S, Wackers FJ, Rozanski A, Botvinick EH, Dae MW, et al. Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology. J Nucl Cardiol 1998;5:218–31.
Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997;38:49–52.
Kurata C, Shouda S, Mikami T, Wakabayashi Y, Nakano T, Sugiyama T, et al. Comparison of [123I]metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine level. J Nucl Cardiol 1997;4:515–23.
Kurata C, Uehara A, Ishikawa A. Improvement of cardiac sympathetic innervation by renal transplantation. J Nucl Med 2004;45: 1114–20.
Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol 2002;9:75–94.
Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts—implications for clinical studies. J Nucl Med 1992;33:1444–50.
Tobes MC, Fig LM, Carey J, Geatti O, Sisson JC, Shapiro B. Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function. J Nucl Med 1989;30:1476–82.
Johnson TS, Young JB, Landsberg L. Norepinephrine turnover in lung: effect of cold exposure and chronic hypoxia. J Appl Physiol 1981;51:614–20.
Gillis CN, Pitt BR. The fate of circulating amines within the pulmonary circulation. Annu Rev Physiol 1982;44:269–81.
Lee YS. Ultrastructural observations of chronic uremic lungs with special reference to histochemical and X-ray microanalytic studies on altered alveolocapillary basement membranes. Am J Nephrol 1985;5:255–66.
Arao T, Takabatake N, Sata M, Abe S, Shibata Y, Honma T, et al. In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med 2003;44:1747–54.
Simmons WW, Freeman MR, Grima EA, Hsia TW, Armstrong PW. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy. Circulation 1994;89:2843–51.
Gill JS, Hunter GJ, Gane G, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993;126:390–8.
Vita G, Bellinghieri G, Trusso A, Costantino G, Santoro D, Monteleone F, et al. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 1999;56:232–7.
Lombardi F, Malliani A, Pagani M, Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 1996;32: 208–16.
Malliani A, Lombardi F, Pagani M. Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 1994;71:1–2.
van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997;95:1449–54.
Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002;105:1354–9.
Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int 2004;65:1568–76.
Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 2003:S105–10.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnológico and Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Rights and permissions
About this article
Cite this article
Parisotto, V., Lima, E.M., Silva, J.M.P. et al. Cardiac sympathetic dysautonomia in children with chronic kidney disease. J Nucl Cardiol 15, 246–254 (2008). https://doi.org/10.1016/j.nuclcard.2008.01.003
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1016/j.nuclcard.2008.01.003